NCT05055804Enrolling by invitation
The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
The ELG Analysis of Glucose a Correlational to Blood Glucose Assa
Source: ClinicalTrials.gov · Last updated 16 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is an investigational study of the ELG medical device to monitor glucose blood level in diabetes mellitus Type 1 and 2 without blood samples in comparison to blood testing methods."Investigational" means the ELG medical device is subjected by the FDA (Food and Drug Administration) for premarket testing requirements. The purpose of this study is to collect data comparison values between ELG testing device to current blood testing methods.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 1 Sept 2021
- Start date
- 11 Aug 2021
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- XP Technology, LLC
- Diseases
- Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT05055804
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 11 Aug 2021 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking drugs of abuse (illegal and/or prescription)
Other
- Have been in another research study in the last 30 days
- Have had a blood transfusion or severe blood loss in the last 14 days
- Have Sickle Cell Anemia
Who the study is looking for
- Have been diagnosed with type 1 or 2 diabetes
- Be 25 - 65 years of age
- Male or female
- Various ethnicities are desired
- Must be available for 2 visits within a 2-4 week period and willing to spend up to 1-2 hours/visit
- Must have daytime availability for visits
- Able to have 1 venous blood draw \& up to 4 fingersticks for complete blood testing at each visit
- Must be willing and able to fast (for at least 6 hours) prior to first visit
Age in the registry: 25 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rouse Family Medical Clinic Coordinator of this site? Confirm its status | Springdale | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.